Promotion Grant Sample Clauses

Promotion Grant. The Executive shall be paid a promotion cash bonus (the “Promotion Cash Grant”) as follows: (i) $275,000 shall be paid on May 31, 2015 and (ii) $275,000 shall be paid on May 31, 2016. Subject to Section 6 hereof, the Executive must be employed by the Company on the respective date each Promotion Cash Grant payment becomes payable to be eligible to receive each such Promotion Cash Grant payment. In addition, the Executive shall be granted, under the terms of the Company’s equity incentive plan and within three (3) business days after the Company becomes current in its filings with the SEC and has an effective Form S-8 available for such grant, a number of restricted shares or units of the common stock, par value $0.01, of the Company (the “Company Stock”) equal in value on the date of grant to $650,000 (the “Promotion Share Grant”). Subject to Section 6 hereof, (i) fifty percent (50%) of the Promotion Share Grant will vest in three (3) equal installments on each of the first, second and third anniversaries of the Commencement Date, subject to the Executive’s continued employment on each such date and (ii) the remaining fifty percent (50%) of the Promotion Share Grant will vest in three (3) equal installments on each of the first, second and third anniversaries of the Commencement Date, subject to (x) the Executive’s continued employment on each such date and (y) the Company Stock achieving a closing trading price of at least $10.00 per share (subject to adjustments for stock splits, corporate reorganization and similar events) for twenty (20) consecutive trading days at any time prior to December 31, 2017. The Promotion Share Grant will be subject to the terms and conditions of an award agreement to be entered into between the Executive and the Company pursuant to the Company’s equity incentive plan.
Sample 1
AutoNDA by SimpleDocs
Promotion Grant. You will receive an equity incentive compensation award of restricted stock units (the “Promotion RSUs”), which will be granted to you on the Grant Date. The number of Promotion RSUs will be $7,000,000 divided by the “Fair Market Value” per share as determined under the Company’s 1999 Omnibus Plan, will vest and be settled in Company common shares on the third anniversary of the Grant Date (the “Vesting Period”), subject, except as set forth herein, to your continued service through such date, and will otherwise be governed by the terms set forth in this Agreement and an award agreement under the Company’s 1999 Omnibus Plan; provided, that upon a termination of your employment by the Company without Cause or your termination of your employment for Good Reason, a pro rata portion of your Promotion RSUs will vest in number equal to the product of (i) the number of unvested Promotion RSUs on the date of termination multiplied by (ii) a fraction, the numerator of which is the number of days in the Vesting Period that you were employed by the Company and the denominator of which is the number of days in the Vesting Period.
Sample 1
Promotion Grant. Upon Employee’s appointment to the office of Executive Vice President, Chief Financial Officer and Secretary, Employee shall be entitled to receive a one-time award of shares of restricted stock of the Company in an amount equal to $200,000, which award shall be made pursuant to the terms and conditions set forth in a grant agreement, the form, terms and conditions of which shall be satisfactory to the Company and its counsel. The terms of such grant agreement shall control with respect to such award notwithstanding any other provision to the contrary in the Original Agreement.
Sample 1
Promotion Grant. As soon as practicable after the Effective Date, but in no event prior to the commencement of the next open window period for Duke Energy, the Executive shall be granted promotion grants (the “Promotion Grants”) with an aggregate grant date value equal to the excess of (i) the sum of (A) 200% of the Executive’s actual annual base salary earned for the portion of 2013 that precedes the Effective Date and (B) 450% of the Executive’s Annual Base Salary for the portion of 2013 beginning on the Effective Date and ending on December 31, 2013 over (ii) the long-term incentive award previously granted to the Executive in 2013 (200% of the Executive actual annual base salary at the time of the grant) (the “Promotion Grant Amount”). The Executive’s Promotion Grants shall consist of (x) a number of target performance shares (“Performance Shares”) based on Duke Energy common Stock (“Duke Common Stock”) equal to the quotient obtained by dividing (I) the product of the Promotion Grant Amount multiplied by 70% by (II) the Fair Market Value (as defined in Plan) of a share of Duke Common Stock as of the date of grant and (y) a number of restricted stock units (“Restricted Stock Units”) based on Duke Common Stock equal to the quotient obtained by dividing (III) the product of the Promotion Grant Amount multiplied by 30% by (IV) the Fair Market Value of a share of Duke Common Stock as of the date of grant. The terms and conditions of the Promotion Grants shall be substantially identical to the terms and conditions of the grants previously made to the Executive in calendar year 2013.
Sample 1
Promotion Grant. Within thirty (30) days following the Effective Date, the Executive shall be granted restricted shares of the common stock, par value $0.01, of ARCP (the “Parent Stock”), subject to the approval of the Board (or the Compensation Committee of the Board), under the terms of ARCP’s Equity Plan (the “Equity Plan”), as follows:
Sample 1
Promotion Grant. In recognition of your promotion to SVP, you received a special grant of Performance Share Units under the Corporation’s 2011 Equity Incentive Plan (the “Equity Plan”) on February 13, 2013 for a target amount of Shares equal to the aggregate Market Price (as defined in the Equity Plan) of Four Hundred Thousand Dollars ($400,000.00) as of the date of grant. That special Performance Share Unit grant shall be in addition to your participation in any annual equity grants that are made to other senior executives under the Equity Plan during your employment with the Corporation. Notwithstanding the foregoing, the equity grant described in this Paragraph 8 shall be in lieu of the grant that was previously made to you pursuant to the special incentive Performance Share Unit program for members of the Corporation’s Key Leadership Team in June of 2012 (the “Special KLT Grant”) and you hereby acknowledge that you forfeit all rights to the Special KLT Grant.
Sample 1
Promotion Grant. In connection with Executive’s promotion to senior vice president, he shall receive an additional restricted stock grant as of April 3, 2023, with a value of $100,000. The restricted stock shall be subject to the terms specified in Paragraph 4C. G.
Sample 1
AutoNDA by SimpleDocs

Related to Promotion Grant

  • Commercialization Plan On a Product by Product basis, not later than sixty (60) days after the filing of the first application for Regulatory Approval of a Product in the Copromotion Territory, the MSC shall prepare and approve a rolling multiyear (not less than three (3) years) plan for Commercializing such Product in the Copromotion Territory (the "Copromotion Territory Commercialization Plan"), which plan includes a comprehensive market development, marketing, sales, supply and distribution strategy for such Product in the Copromotion Territory. The Copromotion Territory Commercialization Plan shall be updated by the MSC at least once each calendar year such that it addresses no less than the three (3) upcoming years. Not later than thirty (30) days after the filing of the first application for Regulatory Approval of a Product in the Copromotion Territory and thereafter on or before September 30 of each calendar year, the MSC shall prepare an annual commercialization plan and budget (the "Annual Commercialization Plan and Budget"), which plan is based on the then current Copromotion Territory Commercialization Plan and includes a comprehensive market development, marketing, sales, supply and distribution strategy, including an overall budget for anticipated marketing, promotion and sales efforts in the upcoming calendar year (the first such Annual Development Plan and Budget shall cover the remainder of the calendar year in which such Product is anticipated to be approved plus the first full calendar year thereafter). The Annual Commercialization Plan and Budget will specify which Target Markets and distribution channels each Party shall devote its respective Promotion efforts towards, the personnel and other resources to be devoted by each Party to such efforts, the number and positioning of Details to be performed by each Party, as well as market and sales forecasts and related operating expenses, for the Product in each country of the Copromotion Territory, and budgets for projected Pre-Marketing Expenses, Sales and Marketing Expenses and Post-Approval Research and Regulatory Expenses. In preparing and updating the Copromotion Territory Commercialization Plan and each Annual Commercialization Plan and Budget, the MSC will take into consideration factors such as market conditions, regulatory issues and competition.

  • Co-Promotion With respect to each Collaboration Product, the Parties shall enter into an agreement that sets forth the terms of the Parties’ Co-Promotion of such Collaboration Products in the Collaboration Territory no later than [**] prior to the anticipated First Commercial Sale of such Collaboration Product in the Collaboration Territory, such terms to be consistent with the high-level terms and principles set forth in this Section 7.6 (each such agreement, a “Co-Promotion Agreement”). The Parties shall Co-Promote the Collaboration Products in the Collaboration Territory pursuant to the terms and conditions of this Agreement and the applicable Co-Promotion Agreement, provided that Verve shall book all sales of Collaboration Products in the Collaboration Territory. Any Co-Promotion Agreement entered into by the Parties pursuant to this Section 7.6 will set forth the terms under which Beam will engage in the Co-Promotion of such Collaboration Product with Verve to primary care physicians, specialists, and other agreed target customers or stakeholders in the Collaboration Territory. Each Party will provide fifty percent (50%) of the promotional effort required to promote the Collaboration Product in the Collaboration Territory at launch and throughout Commercialization in this Agreement and the allocation of the promotional effort between the Parties will be made on an equitable basis as to both the quality and quantity of the activities to be undertaken, including the identity of target prescribers and the nature of the Details. Costs incurred by the Parties for Co-Promotion activities under the Co-Promotion Agreement shall be Shared Commercialization Costs unless otherwise mutually agreed by the Parties and expressly set forth in the Co-Promotion Agreement. For clarity, the applicable Co-Promotion Agreement shall automatically be terminated on the applicable Opt-Out Date in the event Beam exercises a Beam Opt-Out Option or Verve exercises a Verve Opt-Out Option with respect to a particular Collaboration Product.

  • Commercialization Plans As soon as practicable after formation of the JCC (following Acucela’s exercise of an Opt-In Right under Section 3.1), the JCC shall prepare and approve the initial Commercialization Plan for Commercialization of the Licensed Product for the Initial Indication in the Initial Formulation (and, if applicable, any New Formulation or Other Indication Product) in the Territory. The Parties shall use Commercially Reasonable Efforts to ensure that such initial Commercialization Plan for Commercialization of the Licensed Product for the Initial Indication in the Initial Formulation is consistent with the general Commercialization Plan outline set forth in Exhibit C attached hereto and incorporated herein (the “General Commercialization Plan Outline”). The JCC shall prepare and approve a separate Commercialization Plan for Commercialization of Licensed Product for the Initial Indication in the Initial Formulation in the Territory and for Commercialization of each Other Indication Product and New Formulation (if any) in the Territory, and shall update and amend each Commercialization Plan not less than annually or more frequently as needed to take into account changed circumstances or completion, commencement or cessation of Commercialization activities not contemplated by the then-current Commercialization Plan. Amendments and revisions to the Commercialization Plan shall be reviewed and discussed, in advance, by the JCC, and Otsuka agrees to consider proposals and suggestions made by Acucela regarding amendments and revisions to the Commercialization Plan. Any amendment or revision to the Commercialization Plan that provides for an increase or decrease in the number of FTEs for any Phase 3b Clinical Trials or Post-Approval Studies as compared to the previous version of the Commercialization Plan, or that provides for addition or discontinuation of tasks or activities as compared to the previous version of the Commercialization Plan, or that moves forward the timetable for activities reflected in the Commercialization Plan, shall provide for a reasonable ramp-up or wind-down period, as applicable, to accommodate a smooth and orderly transition of Commercialization activities to the amended or revised Commercialization Plan. Each Commercialization Plan shall identify the goals of Commercialization contemplated thereunder and shall address Commercialization (including Co-Promotion) activities related to the Licensed Product (including, if applicable, any Other Indication Product), including:

  • Marketing Plan The Contractor shall have a Marketing Plan, that has been prior-approved by the SDOH and/or LDSS, that describes the Marketing activities the Contractor will undertake within the local district during the term of this Agreement. The Marketing Plan and all marketing activities must be consistent with the Marketing Guidelines which are set forth in Appendix D, which is hereby made a part of this Agreement as if set forth fully herein. The Marketing Plan shall be kept on file in the offices of the Contractor, LDSS, and the SDOH. The Marketing Plan may be modified by the Contractor subject to prior written approval by the SDOH and/or the LDSS. The LDSS or SDOH must take action on the changes submitted within sixty (60) calendar days of submission or the Contractor may deem the changes approved.

  • Promotion Details of all project promotional activities, plus anticipated, related expenditures, that are intended to the LICENSED VARIETY achieves its maximum market potential.

  • The Program The Program in object code form and related Documentation provided to HP hereunder are deemed non-confidential, and HP is not under any obligation to SA to restrict access to or use of such Program in object code form or related Documentation, provided HP complies with the terms of this Agreement.

  • Joint Commercialization Committee As of the Effective Date, the Parties have established a joint commercialization committee (the “Joint Commercialization Committee” or the “JCC”), composed of up to [ * ] representatives of each Party, to monitor and discuss the Commercialization of Products at the operational level. Each JCC representative shall have knowledge and expertise in the commercialization of products similar to Products. The JCC shall in particular:

  • Bonus Program You will be eligible for an annual target bonus of 35% of your annual base salary as determined by the Board in its sole discretion based upon, among other things, the achievement of pre-determined performance milestones. Any annual bonus, if earned, shall be paid no later than March 15th of the year immediately following the year to which the applicable annual bonus relates.

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Commercialization Activities Within North America, the Parties will use Commercially Reasonable Efforts to Commercialize Licensed Products in the Field. In addition, within North America and subject to Section 2.7.6, the Parties will use Commercially Reasonable Efforts to conduct the Commercialization activities assigned to them pursuant to the Commercialization Plan/Budget, including the performance of detailing in accordance therewith. In conducting the Commercialization activities, the Parties will comply with all Applicable Laws, applicable industry professional standards and compliance policies of Celgene which have been previously furnished to Acceleron, as the same may be updated from time to time and provided to Acceleron. Neither Party shall make any claims or statements with respect to the Licensed Products that are not strictly consistent with the product labeling and the sales and marketing materials approved for use pursuant to the Commercialization Plan/Budget.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!